Related Experiment Video
Updated: Jun 28, 2026

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
Radiobiological Characterization of 60-keV Quasimonoenergetic Convergent Photons
Yogesh Rai1, Mojtaba Hoseini-Ghahfarokhi1, Scott J Bright1
1Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Low-energy 60-keV convergent photons show biological effectiveness comparable or superior to standard 6-MV clinical beams. This novel photon system demonstrates potential for lung cancer treatment, with similar efficacy to orthovoltage radiation.
Area of Science:
- Radiation oncology
- Medical physics
- Cancer biology
Background:
- Clinical photon beams, including 6-MV linear accelerator (linac) and orthovoltage units, are standard in cancer therapy.
- Low-energy photon systems offer potential for targeted biological effects.
- Understanding the relative biological effectiveness (RBE) of different photon energies is crucial for optimizing radiation therapy.
Purpose of the Study:
- To compare the biological effects of novel 60-keV quasi-monoenergetic convergent photons with conventional 6-MV linac and orthovoltage (∼60 keV) photon beams.
- To assess the relative biological effectiveness (RBE) and cell kill capabilities of these photon sources across various lung cancer cell lines and a normal bronchial epithelial cell line.
- To evaluate the in vivo efficacy of 60-keV convergent photons in a human lung cancer xenograft model.
Main Methods:
- Irradiation of human (NCI-H460, NCI-H2172) and murine (KLN-205, LKR-13) lung cancer cell lines, and a normal human bronchial epithelial cell line (Beas-2B) using a 6-MV linac, an 180 kVp orthovoltage unit, and a 60-keV convergent photon system.
- Clonogenic cell survival assays to determine dose-response and RBE.
- DNA damage and cell cycle analyses in human lung cancer cell lines.
- Tumor growth delay assessment in an NCI-H460 human lung cancer xenograft model.
Main Results:
- 60-keV convergent and orthovoltage photons induced comparable cell kill and RBE to 6-MV photons in LKR-13, KLN-205, and Beas-2B cells.
- These low-energy photons demonstrated higher cell kill and RBE in NCI-H460 and NCI-H2172 lung cancer cells compared to 6-MV photons.
- Enhanced DNA damage signaling and cell cycle checkpoint activation were observed in NCI-H460 cells treated with orthovoltage and 60-keV convergent photons.
- The 60-keV convergent photon system significantly delayed tumor growth in vivo, comparable to 6-MV photons.
Conclusions:
- The biological effectiveness of 60-keV quasi-monoenergetic convergent photons is comparable to orthovoltage photons (∼60 keV).
- This novel photon system demonstrated comparable or superior biological effectiveness to 6-MV linac photons across tested cell lines.
- In vitro and in vivo results support the potential of 60-keV convergent photons as an effective radiation modality for lung cancer treatment.
Related Concept Videos
Absorption of Radiation
Radiation: Applications
The average...
Biological Effects of Radiation
Atomic Absorption Spectroscopy: Radiation and Light Sources
Two common narrow-range 'line' sources used in AAS are hollow-cathode lamps (HCLs) and...
X-ray Imaging
Types of Radioactivity
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:

